Hing Sham, SVP of Chemistry at Global Blood Therapeutics, Inc. (GBT), bought 2,000 shares at $20.00 ($40K) on 2015-08-17, disclosed to the SEC on 2016-01-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.